{"entity":{"type":"insider","cik":"0001662394","url":"/insider/0001662394","json_url":"/insider/0001662394.json","name":"Ward Keith Wayne","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":8,"first":"2018-06-07","last":"2019-02-27","span_basis":"filed_date"},"name_variants":[{"name":"Ward Keith Wayne","source":"filing","n_filings":8,"first_seen":"2018-06-07","last_seen":"2019-02-27"}],"transactions":[{"id":7875519,"accession":"0001209191-19-014057","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-014057","line_url":"/filing/0001209191-19-014057","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662394","owner_name":"Ward Keith Wayne","owner_display_name":"Ward Keith Wayne","owner_url":"/insider/0001662394","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25184.0,"shares_display":"25,184","price_per_share":91.20598554637866,"price_display":"91.21","price_state":"stated","total_value":2296931.54,"total_display":"2,296,931.54","total_whole":"2,296,932","shares_owned_after":16987.0,"shares_owned_after_display":"16,987","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-26","filed_date":"2019-02-27","scope":"insider","n_lines":2},{"id":7875511,"accession":"0001209191-19-014057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-014057","line_url":"/filing/0001209191-19-014057#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662394","owner_name":"Ward Keith Wayne","owner_display_name":"Ward Keith Wayne","owner_url":"/insider/0001662394","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15183.0,"shares_display":"15,183","price_per_share":91.0,"price_display":"91.00","price_state":"stated","total_value":1381653.0,"total_display":"1,381,653.00","total_whole":"1,381,653","shares_owned_after":8620.0,"shares_owned_after_display":"8,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-25","filed_date":"2019-02-27","scope":"insider"},{"id":8723895,"accession":"0001209191-19-006341","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-006341","line_url":"/filing/0001209191-19-006341","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662394","owner_name":"Ward Keith Wayne","owner_display_name":"Ward Keith Wayne","owner_url":"/insider/0001662394","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4150.0,"shares_display":"4,150","price_per_share":76.69930361445783,"price_display":"76.70","price_state":"stated","total_value":318302.11,"total_display":"318,302.11","total_whole":"318,302","shares_owned_after":8620.0,"shares_owned_after_display":"8,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-31","filed_date":"2019-02-01","scope":"insider","n_lines":2},{"id":8188726,"accession":"0001209191-19-000798","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-000798","line_url":"/filing/0001209191-19-000798","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662394","owner_name":"Ward Keith Wayne","owner_display_name":"Ward Keith Wayne","owner_url":"/insider/0001662394","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4150.0,"shares_display":"4,150","price_per_share":53.98672289156627,"price_display":"53.99","price_state":"stated","total_value":224044.9,"total_display":"224,044.90","total_whole":"224,045","shares_owned_after":1320.0,"shares_owned_after_display":"1,320","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-03","scope":"insider","n_lines":2},{"id":6456482,"accession":"0001209191-18-057707","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-057707","line_url":"/filing/0001209191-18-057707","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662394","owner_name":"Ward Keith Wayne","owner_display_name":"Ward Keith Wayne","owner_url":"/insider/0001662394","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4750.0,"shares_display":"4,750","price_per_share":66.97030947368421,"price_display":"66.97","price_state":"stated","total_value":318108.97,"total_display":"318,108.97","total_whole":"318,109","shares_owned_after":1053.0,"shares_owned_after_display":"1,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-07","filed_date":"2018-11-08","scope":"insider","n_lines":2},{"id":6370410,"accession":"0001209191-18-056805","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-056805","line_url":"/filing/0001209191-18-056805#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662394","owner_name":"Ward Keith Wayne","owner_display_name":"Ward Keith Wayne","owner_url":"/insider/0001662394","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4750.0,"shares_display":"4,750","price_per_share":59.48,"price_display":"59.48","price_state":"stated","total_value":282530.0,"total_display":"282,530.00","total_whole":"282,530","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-01","filed_date":"2018-11-01","scope":"insider"},{"id":6267750,"accession":"0001209191-18-056013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-056013","line_url":"/filing/0001209191-18-056013#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662394","owner_name":"Ward Keith Wayne","owner_display_name":"Ward Keith Wayne","owner_url":"/insider/0001662394","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14250.0,"shares_display":"14,250","price_per_share":57.08,"price_display":"57.08","price_state":"stated","total_value":813390.0,"total_display":"813,390.00","total_whole":"813,390","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-23","filed_date":"2018-10-24","scope":"insider"},{"id":5965228,"accession":"0001209191-18-041949","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-041949","line_url":"/filing/0001209191-18-041949#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662394","owner_name":"Ward Keith Wayne","owner_display_name":"Ward Keith Wayne","owner_url":"/insider/0001662394","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4750.0,"shares_display":"4,750","price_per_share":36.62,"price_display":"36.62","price_state":"stated","total_value":173945.0,"total_display":"173,945.00","total_whole":"173,945","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-05","filed_date":"2018-07-09","scope":"insider"},{"id":6862736,"accession":"0001209191-18-036228","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-036228","line_url":"/filing/0001209191-18-036228#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662394","owner_name":"Ward Keith Wayne","owner_display_name":"Ward Keith Wayne","owner_url":"/insider/0001662394","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28500.0,"shares_display":"28,500","price_per_share":36.62,"price_display":"36.62","price_state":"stated","total_value":1043670.0,"total_display":"1,043,670.00","total_whole":"1,043,670","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-05","filed_date":"2018-06-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001358762","name":"REATA PHARMACEUTICALS INC","url":"/issuer/0001358762","role":"Officer (Chief Development Officer)","n_filings":8,"first_seen":"2018-06-07","last_seen":"2019-02-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001662394","retrieved_at":"2026-08-26T08:27:20+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}